Several studies have documented dysregulated expression of LSM1 in various cancer types, including lung cancer [7], prostate cancer [8], and breast cancer [9], indicating its potential as an oncogenic driver promoting tumor cell proliferation, invasion, and metastasis in multiple malignancies [10]. Here, LSM1 is linked to breast carcinoma.